97 related articles for article (PubMed ID: 15800709)
1. CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease.
Berstein L; Zimarina T; Kovalevskij A; Maximov S; Volkov O; Thijssen JH
Neoplasma; 2005; 52(2):115-8. PubMed ID: 15800709
[TBL] [Abstract][Full Text] [Related]
2. Aromatase and comparative response to its inhibitors in two types of endometrial cancer.
Berstein L; Kovalevskij A; Zimarina T; Maximov S; Gershfeld E; Vasilyev D; Baisheva S; Baymakhasheva A; Thijssen JH
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):71-4. PubMed ID: 15939586
[TBL] [Abstract][Full Text] [Related]
3. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
4. Development and optimization of a Q-RT PCR method to quantify CYP19 mRNA expression in testis of male adult Xenopus laevis: comparisons with aromatase enzyme activity.
Park JW; Hecker M; Murphy MB; Jones PD; Solomon KR; Van Der Kraak G; Carr JA; Smith EE; du Preez L; Kendall RJ; Giesy JP
Comp Biochem Physiol B Biochem Mol Biol; 2006 May; 144(1):18-28. PubMed ID: 16492402
[TBL] [Abstract][Full Text] [Related]
5. Endometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosis.
Hatok J; Zubor P; Galo S; Kirschnerova R; Dobrota D; Danko J; Racay P
Gynecol Endocrinol; 2011 May; 27(5):331-6. PubMed ID: 20553220
[TBL] [Abstract][Full Text] [Related]
6. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.
Berstein LM; Imyanitov EN; Kovalevskij AJ; Maximov SJ; Vasilyev DA; Buslov KG; Sokolenko AP; Iyevleva AG; Chekmariova EV; Thijssen JH
Cancer Lett; 2004 Apr; 207(2):191-6. PubMed ID: 15072828
[TBL] [Abstract][Full Text] [Related]
7. [Aromatase gene expression and its modifying factors in breast tumor tissue].
Berstein LM; Larionov AA; Pauley RJ; Chernitsa OI; Semiglazov VF; Yue W; Edamatsu Kh; Ito Kh; Santen R
Vopr Onkol; 1999; 45(5):504-10. PubMed ID: 10629706
[TBL] [Abstract][Full Text] [Related]
8. [A polymorphism study of the CYP19 gene in endometrial cancer patients].
Bershteĭn LM; Imianitov EN; Suspitsyn EN; Grigor'ev MIu; Sokolov EP; Togo AV; Khanson KP; Poroshina TE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Volkov ON
Vopr Onkol; 2000; 46(3):302-5. PubMed ID: 10976276
[TBL] [Abstract][Full Text] [Related]
9. [Tumor tissue aromatase and estrogen levels versus clinical course of endometrial cancer].
Bersteĭn LM; Chernobrovkina AE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Maksimov SIa; Chepik OF; Gershfel'd ED
Vopr Onkol; 2003; 49(1):55-9. PubMed ID: 12715371
[TBL] [Abstract][Full Text] [Related]
10. Expression of CYP19 (aromatase) mRNA in the human temporal lobe.
Stoffel-Wagner B; Watzka M; Steckelbroeck S; Schwaab R; Schramm J; Bidlingmaier F; Klingmüller D
Biochem Biophys Res Commun; 1998 Mar; 244(3):768-71. PubMed ID: 9535740
[TBL] [Abstract][Full Text] [Related]
11. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
12. Aromatase expression was not detected by immunohistochemistry in endometrial cancer.
Jeon YT; Park SY; Kim YB; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():70-5. PubMed ID: 17404019
[TBL] [Abstract][Full Text] [Related]
13. Expression of aromatase and 5-alpha-reductase genes in endometrial adenocarcinoma.
Kazmierczak W; Skalba P; Dabkowska-Huc A; Samojedny A
Pathol Res Pract; 2006; 202(11):789-91. PubMed ID: 17010533
[TBL] [Abstract][Full Text] [Related]
14. Aromatase (CYP19) expression in tumor-infiltrating lymphocytes and blood mononuclears.
Berstein LM; Larionov AA; Poroshina TE; Zimarina TS; Leenman EE
J Cancer Res Clin Oncol; 2002 Mar; 128(3):173-6. PubMed ID: 11935306
[TBL] [Abstract][Full Text] [Related]
15. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors.
Bulun SE; Economos K; Miller D; Simpson ER
J Clin Endocrinol Metab; 1994 Dec; 79(6):1831-4. PubMed ID: 7989490
[TBL] [Abstract][Full Text] [Related]
16. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
[TBL] [Abstract][Full Text] [Related]
17. [Aromatase activity and its gene expression in tumor tissue of smokers and non-smokers with breast cancer].
Berstein LM; Larionov AA; Chernitsa OI; Kolesnik OS; Manikhas AG
Vopr Onkol; 1998; 44(6):680-2. PubMed ID: 10087963
[TBL] [Abstract][Full Text] [Related]
18. [The risk of endometrial cancer appearance and CYP19 and COMT gene polymorphism].
Szyłło K; Smolarz B; Romanowicz-Makowska H; Przybyłowska K; Lewy J; Kulig B
Pol Merkur Lekarski; 2007 Mar; 22(129):208-10. PubMed ID: 17682677
[TBL] [Abstract][Full Text] [Related]
19. Different promoter usage for CYP19 gene expression in buffalo ovary and placenta.
Sharma D; Ghai S; Singh D
Gen Comp Endocrinol; 2009 Jul; 162(3):319-28. PubMed ID: 19375426
[TBL] [Abstract][Full Text] [Related]
20. Elevated aromatase expression correlates with cervical carcinoma progression.
Veerapaneni P; Kirma N; Nair HB; Hammes LS; Hall KL; Tekmal RR
Gynecol Oncol; 2009 Sep; 114(3):496-500. PubMed ID: 19555998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
